Investing in the Brain: a Generalist Investor Guide to Spotting Winning Neurotech Startups

The blueprint for a stellar neurotech company remains a puzzle. Investors have not yet established quantifiable methods of evaluating neurotech companies comparable to those applied in other industries. For example, companies operating in the software as a service (SaaS) market can rely on what is known as ‘SaaS napkins’, a collection of metrics that a company should hit to be considered by venture capitalists (VCs). Building companies and raising capital are particularly challenging in the absence of a consensus on criteria and metrics for what constitutes success — or at least the promise of it.

Website